Cargando…
A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness
Background and Objectives: Intensive care unit-acquired weakness (ICU-AW) is one of the most frequent neuromuscular complications in critically ill patients. We conducted a global survey to evaluate the current practices of diagnostics, treatment and prevention in patients with ICU-AW. Materials and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416039/ https://www.ncbi.nlm.nih.gov/pubmed/36013535 http://dx.doi.org/10.3390/medicina58081068 |
_version_ | 1784776381254598656 |
---|---|
author | Klawitter, Felix Oppitz, Marie-Christine Goettel, Nicolai Berger, Mette M. Hodgson, Carol Weber-Carstens, Steffen Schaller, Stefan J. Ehler, Johannes |
author_facet | Klawitter, Felix Oppitz, Marie-Christine Goettel, Nicolai Berger, Mette M. Hodgson, Carol Weber-Carstens, Steffen Schaller, Stefan J. Ehler, Johannes |
author_sort | Klawitter, Felix |
collection | PubMed |
description | Background and Objectives: Intensive care unit-acquired weakness (ICU-AW) is one of the most frequent neuromuscular complications in critically ill patients. We conducted a global survey to evaluate the current practices of diagnostics, treatment and prevention in patients with ICU-AW. Materials and Methods: A pre-survey was created with international experts. After revision, the final survey was endorsed by the European Society of Intensive Care Medicine (ESICM) using the online platform SurveyMonkey(®). In 27 items, we addressed strategies of diagnostics, therapy and prevention. An invitation link was sent by email to all ESICM members. Furthermore, the survey was available on the ESICM homepage. Results: A total of 154 healthcare professionals from 39 countries participated in the survey. An ICU-AW screening protocol was used by 20% (28/140) of participants. Forty-four percent (62/141) of all participants reported performing routine screening for ICU-AW, using clinical examination as the method of choice (124/141, 87.9%). Almost 63% (84/134) of the participants reported using current treatment strategies for patients with ICU-AW. The use of treatment and prevention strategies differed between intensivists and non-intensivists regarding the reduction in sedatives (80.0% vs. 52.6%, p = 0.002), neuromuscular blocking agents (76.4% vs. 50%, p = 0.004), corticosteroids (69.1% vs. 37.2%, p < 0.001) and glycemic control regimes (50.9% vs. 23.1%, p = 0.002). Mobilization and physical activity are the most frequently reported treatment strategies for ICU-AW (111/134, 82.9%). The availability of physiotherapists (92/134, 68.7%) and the lack of knowledge about ICU-AW within the medical team (83/134, 61.9%) were the main obstacles to the implementation of the strategies. The necessity to develop guidelines for the screening, diagnosing, treatment and prevention of ICU-AW was recognized by 95% (127/133) of participants. Conclusions: A great heterogeneity regarding diagnostics, treatment and prevention of ICU-AW was reported internationally. Comprehensive guidelines with evidence-based recommendations for ICU-AW management are needed. |
format | Online Article Text |
id | pubmed-9416039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94160392022-08-27 A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness Klawitter, Felix Oppitz, Marie-Christine Goettel, Nicolai Berger, Mette M. Hodgson, Carol Weber-Carstens, Steffen Schaller, Stefan J. Ehler, Johannes Medicina (Kaunas) Article Background and Objectives: Intensive care unit-acquired weakness (ICU-AW) is one of the most frequent neuromuscular complications in critically ill patients. We conducted a global survey to evaluate the current practices of diagnostics, treatment and prevention in patients with ICU-AW. Materials and Methods: A pre-survey was created with international experts. After revision, the final survey was endorsed by the European Society of Intensive Care Medicine (ESICM) using the online platform SurveyMonkey(®). In 27 items, we addressed strategies of diagnostics, therapy and prevention. An invitation link was sent by email to all ESICM members. Furthermore, the survey was available on the ESICM homepage. Results: A total of 154 healthcare professionals from 39 countries participated in the survey. An ICU-AW screening protocol was used by 20% (28/140) of participants. Forty-four percent (62/141) of all participants reported performing routine screening for ICU-AW, using clinical examination as the method of choice (124/141, 87.9%). Almost 63% (84/134) of the participants reported using current treatment strategies for patients with ICU-AW. The use of treatment and prevention strategies differed between intensivists and non-intensivists regarding the reduction in sedatives (80.0% vs. 52.6%, p = 0.002), neuromuscular blocking agents (76.4% vs. 50%, p = 0.004), corticosteroids (69.1% vs. 37.2%, p < 0.001) and glycemic control regimes (50.9% vs. 23.1%, p = 0.002). Mobilization and physical activity are the most frequently reported treatment strategies for ICU-AW (111/134, 82.9%). The availability of physiotherapists (92/134, 68.7%) and the lack of knowledge about ICU-AW within the medical team (83/134, 61.9%) were the main obstacles to the implementation of the strategies. The necessity to develop guidelines for the screening, diagnosing, treatment and prevention of ICU-AW was recognized by 95% (127/133) of participants. Conclusions: A great heterogeneity regarding diagnostics, treatment and prevention of ICU-AW was reported internationally. Comprehensive guidelines with evidence-based recommendations for ICU-AW management are needed. MDPI 2022-08-08 /pmc/articles/PMC9416039/ /pubmed/36013535 http://dx.doi.org/10.3390/medicina58081068 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Klawitter, Felix Oppitz, Marie-Christine Goettel, Nicolai Berger, Mette M. Hodgson, Carol Weber-Carstens, Steffen Schaller, Stefan J. Ehler, Johannes A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness |
title | A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness |
title_full | A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness |
title_fullStr | A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness |
title_full_unstemmed | A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness |
title_short | A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit—Acquired Weakness |
title_sort | global survey on diagnostic, therapeutic and preventive strategies in intensive care unit—acquired weakness |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416039/ https://www.ncbi.nlm.nih.gov/pubmed/36013535 http://dx.doi.org/10.3390/medicina58081068 |
work_keys_str_mv | AT klawitterfelix aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT oppitzmariechristine aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT goettelnicolai aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT bergermettem aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT hodgsoncarol aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT webercarstenssteffen aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT schallerstefanj aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT ehlerjohannes aglobalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT klawitterfelix globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT oppitzmariechristine globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT goettelnicolai globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT bergermettem globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT hodgsoncarol globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT webercarstenssteffen globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT schallerstefanj globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness AT ehlerjohannes globalsurveyondiagnostictherapeuticandpreventivestrategiesinintensivecareunitacquiredweakness |